EFFICACY OF HIGH INTENSITY FOCUSED ULTRASOUND THERAPY FOR UTERINE LEIOMYOMA IN ATHLETES

Abstract

Objective: To evaluate the effectiveness of High-Intensity Focused Ultrasound (HIFU) therapy for treating uterine leiomyoma in athletes, focusing on its benefits for rapid recovery and minimal invasiveness. Methods: Uterine leiomyoma significantly impacts the quality of life, particularly in female athletes, where rapid recovery and minimal downtime are crucial. Traditional treatments such as medication and surgery often fall short in addressing these concerns due to their invasive nature and longer recovery periods. HIFU presents a non-invasive alternative that promises quicker recovery without the complications associated with conventional treatments. This review examines the basic characteristics of HIFU and its clinical applications, emphasizing its suitability for athletes. Results: HIFU therapy, characterized by its non-invasive approach, lacks radioactivity and typically results in fewer complications and injuries compared to traditional methods. It stands out for its rapid postoperative recovery, which is essential for athletes who need to return to training and competition swiftly. The application of HIFU in uterine leiomyoma treatment has shown promising results in reducing tumor size effectively with minimal side effects, thereby maintaining athletic performance and quality of life. Conclusion: High-Intensity Focused Ultrasound (HIFU) therapy is increasingly recognized as a valuable treatment option for uterine leiomyoma in the clinical setting, especially suitable for athletes. Its non-invasive nature and rapid recovery profile make it an ideal option for those who cannot afford prolonged downtime. Further clinical studies and trials are recommended to optimize protocols and confirm long-term outcomes, ensuring that HIFU can be fully integrated into the therapeutic arsenal for athlete-specific healthcare management.